Invention Grant
- Patent Title: Cyclic 11-beta hydroxysteroid dehydrogenase type I inhibitors
- Patent Title (中): 环状11-β羟基类固醇脱氢酶I型抑制剂
-
Application No.: US11843015Application Date: 2007-08-22
-
Publication No.: US07727978B2Publication Date: 2010-06-01
- Inventor: Xiang-Yang Ye , Jeffrey A. Robl
- Applicant: Xiang-Yang Ye , Jeffrey A. Robl
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Terence J. Bogie
- Main IPC: A61K31/397
- IPC: A61K31/397 ; C07D206/00
Abstract:
Novel compounds are provided which are 11-beta-hydroxysteroid dehydrogenase type I inhibitors. 11-Beta-hydroxysteroid dehydrogenase type I inhibitors are useful in treating, preventing, or slowing the progression of diseases requiring 11-beta-hydroxysteroid dehydrogenase type I inhibitor therapy. These novel compounds have the structure: enantiomers, diastereomers, solvates, or salts thereof, wherein A, W, X and Z are defined herein.
Public/Granted literature
- US20080234249A1 CYCLIC 11-BETA HYDROXYSTEROID DEHYDROGENASE TYPE I INHIBITORS Public/Granted day:2008-09-25
Information query
